CELL AND TISSUE CULTURE SUPPLIES MARKET ANALYSIS

Market Challenges And Opportunities

Global Cell and Tissue Culture Supplies Market Restraints

High Cost of Cell Culture Technique

The high cost of cell and tissue culturing is expected to hamper the global cell and tissue culture supplies market growth. For instance, according to an article published by Journal of Biotechnology Advances, on April 28, 2020, the high cost associated with culturing is due to challenging scale up techniques. It is difficult to culture cell on large scale as there is high risk of contamination during cell culturing. It will contaminate the whole product.

To counterbalance this restraint, a robust protocol should be introduce to develop a tissue culture.

Lack of Infrastructure for Cell Culture

In emerging economies, lack of infrastructure facilities is expected to hamper the global cell and tissue culture supplies market growth. For instance, according to an article published in Journal Advances in Agriculture, on August 4, 2021, the major limitations faced by cell culture industry in emerging economies is inadequate funding for laboratory work, lack of infrastructure and utility services, and lack of experienced tissue culture personnel. Furthermore, an available engineer or qualified technician for maintenance and repair of tissue culture equipment are limited. The overall facility maintenance is also difficult for laboratories.

To counterbalance this restrain, more training to personnel and more funding by governments for research activities should be allocated.

Global Cell and Tissue Culture Supplies Market- Key Players

Major players operating in the global cell and tissue culture supplies market include Becton, Dickinson, and Company, Merck KGaA, Corning, Inc., Lonza Group, Eppendorf AG, Thermo Fisher Scientific, Inc., Affymetrix, Inc., GE Healthcare, VWR International, LLC, and WHEATON Industries, Inc.

Global Cell and Tissue Culture Supplies Market – Drivers

Increasing Research and Development Activities In Tissue Culture and Cell Engineering

Increasing research and development in the field of cell and tissue engineering is expected to drive the global cell and tissue culture supplies market growth over the forecast period. For instance, on March 17, 2020, researchers from Seoul National University, South Korea, carried a study. This study proposed a method to model biomechanical-stimuli-induced blood vessel compression in vitro within a polydimethylsiloxane (PDMS) microfluidic 3D microvascular tissue culture platform with an integrated pneumatically actuated compression mechanism. 3D microvascular tissues were cultured within the device.

Increasing Launches of New Technologies and Products for Cell Culture

Increasing launch of new products to make the tissue culture process more efficient is expected to drive the global cell and tissue culture supplies market growth. For instance, on March 11, 2022, Cellink AB, a Sweden-based biotechnology company, launched the BIO CELLX platform, a novel biodispensing tool to automate 3D cell culture. It automates 3D cell culture workflows by leveraging pre-validated protocols. Bio cellx builds upon Cellink's impressive bio printing portfolio uses proven technologies like the patented clean chamber combined with a unique new method for effortless mixing of hydrogels and cells, high precision dispensing, and automatic nozzle priming to create a system for reproducible and high-throughput model generation.